Atlas Trials

Prediction of Amyloid and Mild Cognitive Impairment in Early Stage Alzheimer's Disease From Remote Speech Phenotyping

Clinical trial NCT04928690 · UNKNOWN

Trial details

NCT number
NCT04928690
Sponsor
Novoic Limited
Status
UNKNOWN
Study type
OBSERVATIONAL
Alzheimer DiseaseAlzheimer's Disease (Incl Subtypes)Mild Cognitive Impairment
Start date
2021-06-20
Primary completion
2021-08-15
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.